Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: Results from a randomized controlled trial

Osteoporosis International

Volumn 25, Issue 6, 2014, Pages 1717-1726

  Sikjaer, T ^a   Rolighed, L ^a   Hess, A ^a   Fuglsang Frederiksen, A ^a   Mosekilde, L ^a   Rejnmark, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Hypoparathyroidism; Muscle function; Quality of life; rhPTH(1 84)

Indexed keywords

CALCIUM; PLACEBO; RECOMBINANT PARATHYROID HORMONE; VITAMIN D; PARATHYROID HORMONE;

ADULT; AGED; ARM; ARTICLE; BODY POSTURAL STABILITY; BODY POSTURE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; DYNAMOMETER; ELBOW FLEXION; ELECTROMYOGRAPHY; FEMALE; HORMONE SUBSTITUTION; HOSPITAL PATIENT; HUMAN; HYPOPARATHYROIDISM; KNEE; MAJOR CLINICAL STUDY; MALE; MOTOR UNIT POTENTIAL; MUSCLE FUNCTION; MUSCLE STRENGTH; MYOPATHY; ORTHOPEDIC DIAGNOSTIC DEVICE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REPEATED CHAIR STANDS TEST; SHORT FORM 36; STADIOMETER PLATFORM; TIMED UP AND GO TEST; TREATMENT OUTCOME; WHO 5 WELL BEING INDEX; BODY COMPOSITION; BODY EQUILIBRIUM; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PSYCHOMETRY; SKELETAL MUSCLE;

ADULT; AGED; BODY COMPOSITION; DOUBLE-BLIND METHOD; ELECTROMYOGRAPHY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPARATHYROIDISM; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PARATHYROID HORMONE; POSTURAL BALANCE; PSYCHOMETRICS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84901827586     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2677-6     Document Type: Article

References (44)

1. Abe S, Tojo K, Ichida K, Shigematsu T, Hasegawa T, Morita M, Sakai O (1996) A rare case of idiopathic hypoparathyroidism with varied neurological manifestations. Intern Med 35:129-134
2. Nora DB, Fricke D, Becker J, Gomes I (2004) Hypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism: case report. Arq Neuropsiquiatr 62:154-157
3. Shane E, McClane KA, Olarte MR, Bilezikian JP (1980) Hypoparathyroidism and elevated muscle enzymes. Neurology 30:192-195
4. Snowdon JA, Macfie AC, Pearce JB (1976) Hypocalcaemic myopathy with paranoid psychosis. J Neurol Neurosurg Psychiatry 39:48-52
5. Syriou V, Kolitsa A, Pantazi L, Pikazis D (2005) Hypoparathyroidism in a patient presenting with severe myopathy and skin rash. Case report and review of the literature. Hormones (Athens) 4:161-64
6. Van Offel JF, De Gendt CM, De Clerck LS, Stevens WJ (2000) High bone mass and hypocalcaemic myopathy in a patient with idiopathic hypoparathyroidism. Clin Rheumatol 19:64-66
7. Walters RO (1979) Idiopathic hypoparathyroidism with extrapyramidal and myopathic features. Arch Dis Child 54:236-238
8. Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215-222
9. Bohrer T, Krannich JH (2007) Depression as a manifestation of latent chronic hypoparathyroidism. World J Biol Psychiatry 8:56-59
10. Lawlor BA (1988) Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome. J Clin Psychiatry 49:317-318
11. Velasco PJ, Manshadi M, Breen K, Lippmann S (1999) Psychiatric aspects of parathyroid disease. Psychosomatics 40:486-490
12. Yamaguchi H, Okamoto K, Shooji M, Morimatsu M, Hirai S (1987) Muscle histology of hypocalcaemic myopathy in hypoparathyroidism. J Neurol Neurosurg Psychiatry 50:817-818
13. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr (2003) Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214-4220
14. Cusano NE, Rubin MR, McMahon DJ, Irani D, Tulley A, Sliney J Jr, Bilezikian JP (2013) The Effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab 98:2356-2361
15. Reppe S, Stilgren L, Abrahamsen B, Olstad OK, Cero F, Brixen K, Nissen-Meyer LS, Gautvik KM (2007) Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 292:E1465-E1473
16. Hoare SR, Usdin TB (2001) Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr Pharm Des 7:689-713
17. Smock SL, Vogt GA, Castleberry TA, Lu B, Owen TA (2001) Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1). Mol Biol Rep 28:235-243
18. Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L (2011) The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res 26:2358-2370
19. Tiainen K, Sipila S, Kauppinen M, Kaprio J, Rantanen T (2009) Genetic and environmental effects on isometric muscle strength and leg extensor power followed up for three years among older female twins. J Appl Physiol 106:1604-1610
20. Rantanen T, Era P, Heikkinen E (1996) Maximal isometric knee extension strength and stair-mounting ability in 75- and 80-year-old men and women. Scand J Rehabil Med 28:89-93
21. Csuka M, McCarty DJ (1985) Simple method for measurement of lower extremity muscle strength. Am J Med 78:77-81
22. Podsiadlo D, Richardson S (1991) The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142-148
23. Thrane G, Joakimsen RM, Thornquist E (2007) The association between timed up and go test and history of falls: the Tromso study. BMC Geriatr 7:1
24. Steffen TM, Hacker TA, Mollinger L (2002) Age- and gender-related test performance in community-dwelling elderly people: six-minute walk test, Berg balance scale, timed up & go test, and gait speeds. Phys Ther 82:128-137
25. Ceria-Ulep CD, Grove J, Chen R, Masaki KH, Rodriguez BL, Donlon TA, Guralnik J, Willcox BJ, Willcox DC, Nigg C, Curb JD (2010) Physical aspects of healthy aging: assessments of three measures of balance for studies in middle-aged and older adults. Curr Gerontol Geriatr Res 2010:849761
26. Era P, Sainio P, Koskinen S, Haavisto P, Vaara M, Aromaa A (2006) Postural balance in a random sample of 7,979 subjects aged 30 years and over. Gerontology 52:204-213
27. Fuglsang-Frederiksen A (2006) The role of different EMG methods in evaluating myopathy. Clin Neurophysiol 117:1173-1189
28. Fuglsang-Frederiksen A, Lo MM, Dahl K (1985) Turns analysis (peak ratio) in EMG using the mean amplitude as a substitute of force measurement. Electroencephalogr Clin Neurophysiol 60:225-227
29. Liguori R, Dahl K, Fuglsang-Frederiksen A, Trojaborg W (1992) Turns-amplitude analysis of the electromyographic recruitment pattern disregarding force measurement. II. Findings in patients with neuromuscular disorders. Muscle Nerve 15:1319-1324
30. Fuglsang-Frederiksen A, Mansson A (1975) Analysis of electrical activity of normal muscle in man at different degrees of voluntary effort. J Neurol Neurosurg Psychiatry 38:683-694
31. Buchthal F, Kamieniecka Z (1982) The diagnostic yield of quantified electromyography and quantified muscle biopsy in neuromuscular disorders. Muscle Nerve 5:265-280
32. Ware JE, Kosinski M, Gandek B (2005) SF-36 Health survey. Manual and interpretation guide
33. Ware JE, Kosinski M, Bjoerner J, Turner-Bowker DM, Gandek B, Maruish ME (2007) Scoring procedures. 2nd edn. 53-64
34. de Wit M, Pouwer F, Gemke RJBJ, Delemarre-van de Waal H, Snoek FJ (2007) Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care 30:2003-2006
35. Sikjaer T, Rejnmark L, Thomsen JS, Tietze A, Bruel A, Andersen G, Mosekilde L (2012) Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res 27:781-788
36. Kaebling R (1962) The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand Suppl 38:1-70
37. Lajeunesse C, Everett J, Laplante L, Villeneuve A, Cote R, Thomas J (1989) Neuropsychology of a psycho-organic syndrome caused by idiopathic hypoparathyroidism. Apropos of a case. Encéphale 15:295-298
38. Divieti P, Inomata N, Chapin K, Singh R, Juppner H, Bringhurst FR (2001) Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells. Endocrinology 142:916-925
39. Usdin TB, Bonner TI, Hoare SR (2002) The parathyroid hormone 2 (PTH2) receptor. Recept Channels 8:211-218
40. Sikjaer T, Amstrup AK, Rolighed L, Kjaer SG, Mosekilde L, Rejnmark L (2013) PTH (1-84) Replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects following 6 months of treatment. J Bone Miner Res; n/a
41. Ware JE, Kosinski M, Bjoerner J, Turner-Bowker DM, Gandek B, Maruish ME (2007) SF-36v2 Health survey standard form disease-specific norms. 2nd edn
42. Winer KK, Yanovski JA, Sarani B, Cutler GB Jr (1998) A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83:3480-3486
43. Winer KK, Sinaii N, Peterson D, Sainz B Jr, Cutler GB Jr (2008) Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389-3395
44. Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler GB Jr (2012) Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 97:391-399